cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System
Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings. 510(k) K223783, from Roche Molecular Systems, Inc. (Pleasanton, CA). Product code QWR, class 2.
As of Nov 20, 2026, K223783 is an FDA 510(k) held by Roche Molecular Systems, Inc., substantially equivalent on Dec 4, 2023 after 353 days, with no recalls tied to it in FDA's recall database.
- Review time: 353 days
- Recalls: 0
- Cited as a predicate by: 1 device
The cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System (cobas SARS-CoV-2) is an automated, real- time reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the rapid in vitro qualitative detection of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in anterior nasal (nasal) and nasopharyngeal swab specimens collected from…
- Id Now Covid-19 2.0K221925 · Abbott Diagnostics Scarborough, Inc. · Aug 10, 2023
- cobas liat SARS-CoV-2 v2 nucleic acid testK243346 · Roche Molecular Systems, Inc. · Apr 11, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Dual Track
- Received
- Dec 16, 2022
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3982
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files